- £218.75bn
- £236.77bn
- $54.07bn
- 78
- 14
- 98
- 73
REG - AstraZeneca PLC - Imfinzi approved in China for extensive-stage SCLC
AnnouncementREG - AstraZeneca PLC - Status on US FDA Advisory Committee for roxadustat
AnnouncementREG - FTSE Russell AstraZeneca PLC - AstraZeneca
AnnouncementREG - Competition and Mkts - Merger Update: AstraZeneca / Alexion
AnnouncementREG - AstraZeneca PLC - AstraZeneca-Alexion transaction cleared in the UK
AnnouncementREG - AstraZeneca PLC - Tezepelumab granted FDA Priority Review for asthma
AnnouncementREG - AstraZeneca PLC - AstraZeneca-Alexion transaction cleared in the EU
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Forxiga recommended in EU for patients with CKD
AnnouncementREG - AstraZeneca PLC - Nirsevimab PhII/III trial confirms safety profile
AnnouncementREG - AstraZeneca PLC - Lynparza approved in China for prostate cancer
AnnouncementREG - AstraZeneca PLC - Orpathys approved in China for lung cancer
AnnouncementREG - AstraZeneca PLC - Koselugo approved in the EU for children with NF1
AnnouncementREG - BMO Cap & Inc InvTst - Portfolio Update
AnnouncementREG - AstraZeneca PLC - Update on AZD7442 STORM CHASER trial
AnnouncementREG - Morgan Stanley & Co. AstraZeneca PLC - Stabilisation Notice
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - BMO Cap & Inc InvTst - Portfolio Update
AnnouncementREG - Stock Exch Notice - Admission to Trading - 03/06/2021
Announcement